AELIS FARMA
New brain disease treatments
- B2B
About AELIS FARMA
Develops unique drug candidates, Signaling Specific inhibitors of the CB1 receptor, for treating various brain pathologies, including cannabis use disorders and cognitive deficits.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Bordeaux, Nouvelle-Aquitaine, France
- Founded
- 2013
- Revenue
- €432KFY2025, publicly reported
- Website
- aelisfarma.com
- linkedin.com/company/aelis-farma
AELIS FARMA at a glance
AELIS FARMA is a B2B company in the Biotechnology Research industry, headquartered in Bordeaux, Nouvelle-Aquitaine, France.
AELIS FARMA was founded in 2013.
AELIS FARMA has 11–50 employees.
AELIS FARMA's revenue is €432K (FY2025, publicly reported).
Frequently asked questions about AELIS FARMA
What is AELIS FARMA's revenue?
AELIS FARMA's revenue is €432K (FY2025, publicly reported).
How many employees does AELIS FARMA have?
AELIS FARMA has 11–50 employees.
Where is AELIS FARMA headquartered?
AELIS FARMA is headquartered in Bordeaux, Nouvelle-Aquitaine, France.
Selling to companies like AELIS FARMA?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies